BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29956737)

  • 1. MicroRNA-381 reduces inflammation and infiltration of macrophages in polymyositis via downregulating HMGB1.
    Liu Y; Gao Y; Yang J; Shi C; Wang Y; Xu Y
    Int J Oncol; 2018 Sep; 53(3):1332-1342. PubMed ID: 29956737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway.
    Yin Y; Li F; Shi J; Li S; Cai J; Jiang Y
    Cell Physiol Biochem; 2016; 40(3-4):486-498. PubMed ID: 27889748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced miR-146a Promotes REG3A Expression and Macrophage Migration in Polymyositis and Dermatomyositis.
    Jiang T; Huang Y; Liu H; Xu Q; Gong Y; Chen Y; Hu X; Han Z; Gao M
    Front Immunol; 2020; 11():37. PubMed ID: 32153557
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-409-3p regulates macrophage migration in polymyositis through targeting CXCR4.
    Ye Q; Chen Z
    Autoimmunity; 2021 Sep; 54(6):353-361. PubMed ID: 34142881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
    Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Downregulates miR-21 Expression and Induces Inflammatory Infiltration of Macrophages in Polymyositis: Role of CXCL10.
    Yan W; Chen C; Chen H
    Mol Neurobiol; 2017 Apr; 54(3):1631-1641. PubMed ID: 26873848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2/ARE pathway inhibits inflammatory infiltration by macrophage in rats with autoimmune myositis.
    Liu Y; Gao Y; Yang J; Shi C; Wang Y; Xu Y
    Mol Immunol; 2019 Jan; 105():165-172. PubMed ID: 30513452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies.
    Shen WS; Xu XQ; Zhai NN; Zhou ZS; Shao J; Yu YH
    Gene Ther; 2017 Jun; 24(6):353-360. PubMed ID: 28440797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway.
    Liu AH; Wu YT; Wang YP
    Brain Res Bull; 2017 Jun; 132():139-149. PubMed ID: 28528202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 up-regulates the MMP-9 expression levels and induces inflammatory infiltration of macrophages in polymyositis through regulating the NF-kB pathway.
    Yan W; Fan W; Chen C; Wu Y; Fan Z; Chen J; Chen Z; Chen H
    Gene; 2016 Oct; 591(1):137-147. PubMed ID: 27374114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo.
    Yuan Z; Luo G; Li X; Chen J; Wu J; Peng Y
    Cell Signal; 2016 Mar; 28(3):158-164. PubMed ID: 26721185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
    Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
    PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-141-3p inhibits the activation of astrocytes and the release of inflammatory cytokines in bacterial meningitis through down-regulating HMGB1.
    Fang X; Wang H; Zhuo Z; Tian P; Chen Z; Wang Y; Cheng X
    Brain Res; 2021 Nov; 1770():147611. PubMed ID: 34403663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma.
    Zhang D; Cao J; Zhong Q; Zeng L; Cai C; Lei L; Zhang W; Liu F
    Biomed Pharmacother; 2017 Nov; 95():1187-1193. PubMed ID: 28931210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms.
    Do T; Tan R; Bennett M; Medvedovic M; Grom AA; Shen N; Thornton S; Schulert GS
    J Leukoc Biol; 2018 Jan; 103(1):71-85. PubMed ID: 29345059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1.
    Tang ST; Wang F; Shao M; Wang Y; Zhu HQ
    Vascul Pharmacol; 2017 Jan; 88():48-55. PubMed ID: 27993686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I.
    Wan Z; Zhang X; Peng A; He M; Lei Z; Wang Y
    Int Immunopharmacol; 2016 Dec; 41():74-81. PubMed ID: 27816788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.